Years of dedication and impact. 👏🏼 Couldn’t be more proud of this well-deserved recognition for our chairman, @esbrilakis, as MSCAI at #SCAI2026! The Master Interventionalist of @SCAI (MSCAI) designation honors outstanding members who have made significant contributions to IC.

The past, present, and future of @PittIMChiefs 🤩💜🚀⭐️🫀 #IST #CST @PittCardiology @DStrepkos (my heart is swelling 🥹 even though I know I missed so many IM alumni 📸)

🎉 See you at NOLA! 🎉 Join us for #ACC26 in New Orleans! Check out the schedule! ⬇️ Feel free to stop by to discuss the latest in research! @esbrilakis @yadersandoval @Bavana_Rangan @PedroEPCarvalho @m1chaella_alex @DStrepkos @ThomasBasala @TheodoreVichos @MHIF_Heart

Congratulations to our CCAD Fellows @DStrepkos and @m1chaella_alex on matching into two outstanding programs, both their 1st choices! We’re so proud of your hard work and excited to see what’s next. #Match2026 @MHIF_Heart @esbrilakis @yadersandoval @Bavana_Rangan

Does predicted post-PCI FFR-CT from CCTA align with observed post-PCI FFRangio? Following our initial report (bit.ly/3Ls5X9H), we now extend these observations by comparing predicted post-PCI FFR-CT with observed post-PCI FFRangio, now in press @CRMjournal (bit.ly/49y4F69). While larger studies are needed, these data support the evolving concept of wireless end-to-end physiology guided PCI, in which assessment of both pre- and post-PCI physiology becomes more practical and accessible, allowing expected post PCI physiology to be defined before entering the catheterization laboratory and verified at the time of PCI from routine angiography. @PedroEPCarvalho @esbrilakis @CCAD_MHIF @MHIF_Heart @Bavana_Rangan @m1chaella_alex @DStrepkos @ColletCarlos

Day 1 of the #CT for #PCI Summit 3.0! Excited to kick things off and learn from the incredible experts here. #CT4PCI @MHIF_Heart @yadersandoval @esbrilakis @JoaoLCavalcante @ziadalinyc @ChinnaiyanMD @FaroucJaffer @OKhaliqueMD @TaylorCharley64

First to take the stage — @yadersandoval — leading us into the world of #CT-guided #PCI. #CT4PCI @MHIF_Heart

@DStrepkos presenting at #ACC25 Can IodixAnol ReducE the incidence of adverse renal or cardiac events in #CTO Interventions (CARE-CTO)? Key conclusion: Iodixanol was associated with lower AKI incidence. @ACCinTouch @esbrilakis @yadersandoval @MHIF_Heart @GEHealthCare